Antabuse 400 mg Effervescent Tablets
Effervescent tablet
Compare
|
PA1986/110/001
Authorised: 06/02/1985
Teva B.V.
|
SPC
PIL
|
Anthisan Cream 2% w/w
Cream
Compare
|
PA1113/024/001
Authorised: 01/04/1979
Phoenix Labs
|
SPC
PIL
|
Anti-Hist Allergy 10mg Film-coated tablets
Film-coated tablet
Compare
|
PA0126/267/001
Authorised: 23/06/2006
Clonmel Healthcare Ltd
|
SPC
PIL
|
Anti-Hist Allergy 1mg/ml Oral Solution
Oral solution
Compare
|
PA0126/267/002
Authorised: 29/05/2015
Clonmel Healthcare Ltd
|
SPC
PIL
|
Anusol Cream
Cream
Compare
|
PA22647/001/001
Authorised: 03/04/1990
SOFIBEL
|
SPC
PIL
|
Anusol HC Ointment
Ointment
Compare
|
PA22647/002/001
Authorised: 30/03/1990
SOFIBEL
|
SPC
PIL
|
Anusol HC Suppositories
Suppository
Compare
|
PA22647/002/002
Authorised: 30/03/1990
SOFIBEL
|
SPC
|
Anusol Ointment
Ointment
Compare
|
PA22647/001/002
Authorised: 03/04/1990
SOFIBEL
|
SPC
PIL
|
Anusol Suppositories
Suppository
Compare
|
PA22647/001/003
Authorised: 03/04/1990
SOFIBEL
|
SPC
|
Anxicalm 10 mg Tablets
Tablet
Compare
|
PA0126/011/003
Authorised: 25/04/1979
Clonmel Healthcare Ltd
|
SPC
PIL
|
Anxicalm 2 mg Tablets
Tablet
Compare
|
PA0126/011/001
Authorised: 25/04/1979
Clonmel Healthcare Ltd
|
SPC
PIL
|
Anxicalm 5 mg Tablets
Tablet
Compare
|
PA0126/011/002
Authorised: 25/04/1979
Clonmel Healthcare Ltd
|
SPC
PIL
|
Apealea
Powder for solution for infusion
Compare
|
EU/1/18/1292/001
Authorised: 20/11/2018
Inceptua AB
|
SPC
PIL
IPAR
|
Apeneta 100 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1347/105/002
Authorised: 22/10/2021
KRKA, d.d., Novo mesto
|
SPC
PIL
|
Apeneta 150 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1347/105/003
Authorised: 22/10/2021
KRKA, d.d., Novo mesto
|
SPC
PIL
|
Apeneta 200 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1347/105/004
Authorised: 22/10/2021
KRKA, d.d., Novo mesto
|
SPC
PIL
|
Apeneta 250 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1347/105/005
Authorised: 22/10/2021
KRKA, d.d., Novo mesto
|
SPC
PIL
|
Apeneta 50 mg prolonged-release tablets
Prolonged-release tablet
Compare
|
PA1347/105/001
Authorised: 22/10/2021
KRKA, d.d., Novo mesto
|
SPC
PIL
|
Apexxnar
Suspension for injection
Compare
|
EU/1/21/1612/001-006
Authorised: 14/02/2022
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Apidra
Solution for injection
Compare
|
EU/1/04/285/021-036
Authorised: 12/01/2010
Sanofi-Aventis Deutschland GmbH
|
SPC
PIL
IPAR
|